UniProtKB/Swiss-Prot P35611: Variant p.Gly460Trp

Alpha-adducin
Gene: ADD1
Feedback?

Variant information Variant position:

460 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Tryptophan (W) at position 460 (G460W, p.Gly460Trp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to large size and aromatic (W) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs4961 [ dbSNP | Ensembl ]

Sequence information Variant position:

460 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

737 The length of the canonical sequence.
Location on the sequence:

QQREKTRWLNSGRGDEASEE G QNGSSPKSKTKWTKEDGHRT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QQREKTRWLNSGRGDEASEEGQNGSSPKSKTKWTKEDGHRT

Mouse                         QQREKTRWLHSGRGDDASEEGQNGSSPKSKTKWTKEDGHRT

Rat                           QQREKTRWLNSGRGDDASEEGQNGSSPKSKTKWTKEDGHRT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 737	Alpha-adducin
Region	421 – 486	Disordered
Modified residue	445 – 445	Phosphothreonine; by ROCK2
Modified residue	464 – 464	Phosphoserine
Modified residue	465 – 465	Phosphoserine
Modified residue	480 – 480	Phosphothreonine; by ROCK2
Alternative sequence	471 – 471	K -> KVWTNITHDHVKPLLQSLSSGVCVPSCITNCL. In isoform 3 and isoform 6.
Mutagenesis	445 – 445	T -> D. Abolishes phosphorylation by ROCK2; when associated with D-480.
Mutagenesis	480 – 480	T -> D. Abolishes phosphorylation by ROCK2; when associated with D-445.

Literature citations
Human alpha-adducin gene, blood pressure, and sodium metabolism.
Kamitani A.; Wong Z.Y.; Fraser R.; Davies D.L.; Connor J.M.; Foy C.J.; Watt G.C.; Harrap S.B.;
Hypertension 32:138-143(1998)
Cited for: VARIANT TRP-460; Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis.
Halushka M.K.; Fan J.-B.; Bentley K.; Hsie L.; Shen N.; Weder A.; Cooper R.; Lipshutz R.; Chakravarti A.;
Nat. Genet. 22:239-247(1999)
Cited for: VARIANTS TRP-460 AND CYS-586;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.